Pediatric psychopharmacology: context, model programs, and considerations for care
- PMID: 22810116
- DOI: 10.1176/appi.ps.201100318
Pediatric psychopharmacology: context, model programs, and considerations for care
Abstract
Research indicates that one in five children and adolescents in the United States has a behavioral or emotional disorder and a substantial number use psychotropic medications. Pediatric primary care providers play an important role in prescribing and managing psychotropic medications. However, they face several challenges with respect to prescribing these medications, including training, confidence, and level of comfort. One way to meet these challenges is through comanagement of behavioral health care, including psychopharmacology, by pediatric primary care providers and child mental health care providers. The authors review literature on patterns of psychotropic medication prescribing for children and adolescents and the role of pediatric primary care providers. They describe two statewide models that were developed to improve pediatric primary care providers' ability to treat patients with behavioral health needs, including prescribing psychotropic medications, by linking them to support from child mental health providers. The authors conclude with recommendations to improve professional training and collaboration.
Similar articles
-
Psychotropic Medication Prescribing in Primary Care: Pediatric Chief Resident Perspectives.Acad Pediatr. 2021 May-Jun;21(4):750-758. doi: 10.1016/j.acap.2020.12.001. Epub 2021 Jan 18. Acad Pediatr. 2021. PMID: 33359584
-
Psychodynamic perspectives on psychotropic medications for children and adolescents.Child Adolesc Psychiatr Clin N Am. 2013 Apr;22(2):351-66. doi: 10.1016/j.chc.2012.12.004. Child Adolesc Psychiatr Clin N Am. 2013. PMID: 23538017
-
Investigating geographic variation in use of psychotropic medications among youth in child welfare.Child Abuse Negl. 2011 May;35(5):333-42. doi: 10.1016/j.chiabu.2011.01.012. Child Abuse Negl. 2011. PMID: 21620160
-
Psychopharmacology in adolescent medicine.Adolesc Med Clin. 2006 Feb;17(1):165-81. doi: 10.1016/j.admecli.2005.10.004. Adolesc Med Clin. 2006. PMID: 16473299 Review.
-
Psychopharmacology of pediatric bipolar disorder.Expert Rev Neurother. 2010 Jul;10(7):1053-88. doi: 10.1586/ern.10.86. Expert Rev Neurother. 2010. PMID: 20586689 Review.
Cited by
-
Providers' Behaviors and Beliefs on Prescribing Antipsychotic Medication to Children: A Qualitative Study.Community Ment Health J. 2018 Jan;54(1):17-26. doi: 10.1007/s10597-017-0125-8. Epub 2017 Mar 31. Community Ment Health J. 2018. PMID: 28364300
-
Prescription Drug Use and Cost Trends Among Medicaid-Enrolled Children with Disruptive Behavioral Disorders.J Behav Health Serv Res. 2018 Oct;45(4):550-564. doi: 10.1007/s11414-018-9605-z. J Behav Health Serv Res. 2018. PMID: 29572707
-
Pharmacogenomics in Children.Methods Mol Biol. 2022;2547:569-593. doi: 10.1007/978-1-0716-2573-6_20. Methods Mol Biol. 2022. PMID: 36068477
-
Trends in Atypical Antipsychotics Prescribed to Children Six Years of Age or Less on Medicaid in Kentucky.J Child Adolesc Psychopharmacol. 2015 Jun;25(5):440-3. doi: 10.1089/cap.2014.0057. Epub 2015 Apr 21. J Child Adolesc Psychopharmacol. 2015. PMID: 25897616 Free PMC article.
-
Dosing and Monitoring: Children and Adolescents.Psychopharmacol Bull. 2018 Feb 5;48(2):34-92. Psychopharmacol Bull. 2018. PMID: 29713099 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources